Trial intelligence / Profile preview

Low-dose abiraterone in prostate cancer

TCTR20211012001Completed

Sponsor
N/A
Start
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

Single-arm trial of abiraterone in prostate cancer (PCa), sponsored by N/A. Started Aug 2019; status: completed.

02

Drugs

abiraterone
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on TCTR20211012001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20211012001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call